New vaccine could battle heroin addiction

July 20, 2011 at 6:52 PM

LA JOLLA, Calif., July 20 (UPI) -- U.S. researchers say they have developed a highly successful vaccine against a heroin high and have proven its therapeutic potential in animal models.

Researchers at the Scripps Research Institute in La Jolla, Calif., say the vaccine produces antibodies -- a kind of immune molecule -- that stop not only heroin but also other psychoactive compounds metabolized from heroin from reaching the brain to produce euphoric effects.

"The hope is that such a protective vaccine will be an effective therapeutic option for those trying to break their addiction to heroin," researcher Kim J. Danda said in a Scripps release Wednesday.

Injection drug abuse costs the United States an estimated $22 billion due to loss of productivity, criminal activity, medical care and social welfare, the researchers said.

Animal studies were extremely encouraging, they said.

"We saw a very robust and specific response from this heroin vaccine," said study co-author George F. Koob. "I think a humanized version could be of real help to those who need and want it."

Related UPI Stories
Latest Headlines
Trending News
Test predicts teen risk factor for cardiovascular disease
Gene therapy effective against form of inherited vision loss
Foot of new human ancestor, Homo naledi, resembles our own
NASA releases thousands of Apollo mission photos on Flickr
Study: European austerity to blame for rise in male suicide